http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2018052002-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2018052002-A1 |
| titleOfInvention | Thrombospondin 1 binding peptide |
| abstract | Disclosed is a compound that can promote angiogenesis by inhibiting the function of TSP1, and is useful for the treatment or prevention of diseases such as severe leg ischemia. Formula (I) [Chemical 1] Wherein A is selected from the linking groups A 1 to A 6 and X aa1 is the residue or presence of an aliphatic amino acid, aromatic amino acid, basic amino acid, neutral amino acid, or acidic amino acid Xaa2 is an aromatic or neutral amino acid residue; Xaa3 is an aliphatic, aromatic, or basic amino acid residue; Xaa4 is Ser, Thr, Ala or be m S,; X aa5 is an Gly or Ser; X aa6 is a residue of a basic amino acid or neutral amino acid; X aa7 is a residue of a neutral amino acid or acidic amino acid ; X aa8 is an aromatic amino acid residue; X aa9 is an aliphatic amino acid, the residue of a neutral amino acid or aromatic amino acid,; X aa10 is a basic amino acid, Aliphatic amino acids, the residue of an aromatic amino acid or neutral amino acid,; X aa11 is an aromatic amino acid residue; X aa12 is an aliphatic amino acid, an aromatic amino acid or a residue of a basic amino acid, Or a pharmacologically acceptable salt thereof. |
| priorityDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.